NASDAQ:VRAY - Viewray Stock Price, Forecast & News

Viewray trades on the NASDAQ under the ticker symbol "VRAY."

Viewray Inc (NASDAQ:VRAY) announced its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.06. The company earned $20.90 million during the quarter, compared to analysts' expectations of $20.66 million. Viewray had a negative net margin of 110.61% and a negative return on equity of 75.41%. Viewray's revenue was up 18.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.39) EPS. View Viewray's Earnings History.

Viewray is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Viewray.

Viewray updated its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $17-17 million, compared to the consensus revenue estimate of $18.27 million.

9 brokers have issued twelve-month price objectives for Viewray's shares. Their forecasts range from $5.00 to $9.00. On average, they anticipate Viewray's share price to reach $6.44 in the next twelve months. This suggests a possible upside of 105.6% from the stock's current price. View Analyst Price Targets for Viewray.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viewray in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Viewray.

News stories about VRAY stock have been trending somewhat negative recently, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Viewray earned a news impact score of -1.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Viewray.

Some companies that are related to Viewray include Natus Medical (NTUS), AxoGen (AXGN), TransMedics Group (TMDX), Cutera (CUTR), Stereotaxis (STXS), Zynex (ZYXI), Semler Scientific (SMLR), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Soleno Therapeutics (SLNO), Fonar (FONR), Edap Tms (EDAP), BioSig Technologies (BSGM), Second Sight Medical Products (EYES) and Fc Global Realty (FCRE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Viewray investors own include Alibaba Group (BABA), Cara Therapeutics (CARA), Corbus Pharmaceuticals (CRBP), Sorrento Therapeutics (SRNE), Amarin (AMRN), Amicus Therapeutics (FOLD), Iovance Biotherapeutics (IOVA), Progenics Pharmaceuticals (PGNX), Pieris Pharmaceuticals (PIRS) and Sarepta Therapeutics (SRPT).

(VRAY) raised $52 million in an initial public offering (IPO) on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

Viewray's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Rhenman & Partners Asset Management AB (0.75%), Kahn Brothers Group Inc. DE (0.54%), Pennsylvania Trust Co (0.13%), California Public Employees Retirement System (0.13%), Joel Isaacson & Co. LLC (0.11%) and Alpine Global Management LLC (0.08%). Company insiders that own Viewray stock include Fmr Llc, International Ltd Fosun, James F Dempsey, Orbimed Advisors Llc, Scott William Drake and Shahriar Matin. View Institutional Ownership Trends for Viewray.

VRAY stock was purchased by a variety of institutional investors in the last quarter, including Kahn Brothers Group Inc. DE, California Public Employees Retirement System, Rhenman & Partners Asset Management AB, Joel Isaacson & Co. LLC, Alpine Global Management LLC, SG Americas Securities LLC, Falcon Point Capital LLC and Pennsylvania Trust Co. Company insiders that have bought Viewray stock in the last two years include International Ltd Fosun, Scott William Drake and Shahriar Matin. View Insider Buying and Selling for Viewray.

Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VRAY stock can currently be purchased for approximately $3.14.

Viewray has a market capitalization of $311.64 million and generates $80.96 million in revenue each year. The company earns $-76,400,000.00 in net income (profit) each year or ($0.98) on an earnings per share basis. View Additional Information About Viewray.

The official website for Viewray is http://www.viewray.com/.

Viewray's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at 440-703-3210 or via email at [email protected]